Marc A. Becker, Chief Financial Officer at CONCERT PHARMACEUTICALS, INC. (CNCE), sold 3,762 shares at $8.33 ($31K) on 2023-02-15, disclosed to the SEC on 2023-02-16.
Scheduled sale ($31k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| CNCE | SELL | 2022-02-16 | $12K | — | Filing → |
| CNCE | SELL | 2022-01-07 | $9K | — | Filing → |
| CNCE | SELL | 2021-08-17 | $24K | — | Filing → |